ArticleNature medicine2022

Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial.

Farid Boulad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.